Opioid Overdose Screening and Naloxone Co-Prescribing to Curb Overdose Deaths
Skip to main content
eScholarship
Open Access Publications from the University of California

UCLA

UCLA Electronic Theses and Dissertations bannerUCLA

Opioid Overdose Screening and Naloxone Co-Prescribing to Curb Overdose Deaths

  • Author(s): Malik, Shamsah
  • Advisor(s): Glasner, Suzette
  • et al.
Abstract

Background: California’s naloxone law (AB 2760) mandates all providers to screen for overdose risk and co-prescribe naloxone to patients at risk of opioid overdose. However, naloxone co-prescription rates among general medicine providers remain low. This can be attributed to lack of knowledge regarding the overdose risk criteria and lack of a consistent standardized approach to prescribing opioids. Objective: This quality improvement (QI) project evaluated the impact of a naloxone provider education intervention coupled with a standardized approach for identifying patients at risk of opioid overdose, on provider knowledge and rates of naloxone co-prescription and overdose education when appropriate. Design/Setting: The project was designed as a pre and posttest analysis of change in opioid screening and naloxone prescriptions among the hospitalist providers at a Los Angeles County (LAC) hospital. Methods/Intervention: A survey assessing knowledge, attitudes and barriers for naloxone prescribing was administered at baseline and after the naloxone provider intervention. All providers were given a one-hour educational intervention focused on a standardized 5-Step process to be adopted for opioid screening and naloxone prescribing. Data were collected from medical charts on all patients discharged with an opioid prescription to determine if: (1) they met overdose risk criteria and (2) were subsequently co-prescribed naloxone, both in the six months before and four months after the educational intervention. For survey analysis, Friedman test was used across three time points and Wilcoxon's Signed-Rank with Bonferroni correction was used for pair-wise comparisons. Chi-square analysis was used to compare prescriber data pre- and post-intervention. Results: More naloxone prescriptions were written during the post-education phase, relative to baseline (68% vs 10%). Providers also educated more patients regarding opioid overdose and naloxone in the post-education phase (44% vs 6%). Providers screened more consistently for overdose risk post-intervention compared with baseline; thus, providing naloxone (85% vs 11%) and overdose education (55% vs 7%) to patients meeting criteria for overdose appropriately. Conclusion: Provider education and utilization of a standardized screening protocol customized for the provider context facilitated appropriate overdose screening, naloxone co-prescription and overdose education to patients. Keywords: opioids, overdose, overdose-risk criteria, naloxone, overdose education

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View